Quantitative Subanalysis of Optical Coherence Tomography after Treatment with Ranibizumab for Neovascular Age-Related Macular Degeneration
Open Access
- 1 July 2008
- journal article
- retina
- Published by Association for Research in Vision and Ophthalmology (ARVO) in Investigative Ophthalmology & Visual Science
- Vol. 49 (7) , 3115-3120
Abstract
Purpose. To investigate the effects of ranibizumab on retinal morphology in patients with neovascular age-related macular degeneration (AMD) using optical coherence tomography (OCT) quantitative subanalysis. methods. Data from 95 patients receiving intravitreal ranibizumab for neovascular AMD were collected. StratusOCT images were analyzed using custom software that allows precise positioning of prespecified boundaries on every B-scan. Changes in thickness/volume of the retina, subretinal fluid (SRF), subretinal tissue (SRT), and pigment epithelial detachments (PEDs) at week 1 and at months 1, 3, 6, and 9 after treatment were calculated. results. Total retinal volume reached its nadir at month 1, with an average reduction of 0.43 mm3 (P < 0.001). By month 9, this initial change had been reduced to a mean reduction of 0.32 mm3 (P = 0.0011). Total SRF volume reached its lowest level by month 1, with an average reduction of 0.24 mm3 (P < 0.001). This reduction lessened subsequently, to 0.18 mm3, by month 9. There was an average 0.3-mm3 decrease in total PED volume by month 1 (P < 0.001), and this later declined further, to 0.45 mm3, by month 9 (P = 0.0014). Total SRT volume was reduced by an average of 0.07 mm3 at month 1 (P = 0.0159) and subsequently remained constant. conclusions. Although neurosensory retinal edema and SRF showed an early reduction to nadir after the initiation of ranibizumab therapy, the effect on the retina was attenuated over time, suggesting possible tachyphylaxis. PED volume showed a slower but progressive reduction. Manual quantitative OCT subanalysis may allow a more precise understanding of anatomic outcomes and their correlation with visual acuity.Keywords
This publication has 16 references indexed in Scilit:
- Angiographic and Optical Coherence Tomographic Results of the MARINA Study of Ranibizumab in Neovascular Age-Related Macular DegenerationOphthalmology, 2007
- Retinal Pigment Epithelial DetachmentSurvey of Ophthalmology, 2007
- An Optical Coherence Tomography-Guided, Variable Dosing Regimen with Intravitreal Ranibizumab (Lucentis) for Neovascular Age-related Macular DegenerationAmerican Journal of Ophthalmology, 2007
- Evaluation of image artifact produced by optical coherence tomography of retinal pathologyAmerican Journal of Ophthalmology, 2005
- Artifacts in optical coherence tomography topographic mapsAmerican Journal of Ophthalmology, 2005
- Pegaptanib for Neovascular Age-Related Macular DegenerationNew England Journal of Medicine, 2004
- The epidemiology of age-related macular degenerationAmerican Journal of Ophthalmology, 2004
- Potential Public Health Impact of Age-Related Eye Disease Study ResultsArchives of Ophthalmology (1950), 2003
- Photodynamic Therapy of Subfoveal Choroidal Neovascularization With VerteporfinArchives of Ophthalmology (1950), 2003
- Laser Photocoagulation of Subfoveal Neovascular Lesions in Age-Related Macular DegenerationArchives of Ophthalmology (1950), 1991